title: [Significance of low molecular weight urinary protein for assessment of early renal damage in patients with multiple myeloma].
abstract: This study was purposed to evaluate the clinical significance of low molecular weight urinary proteins for diagnosis of early renal damage in patients with multiple myeloma (MM). Medical records of 278 patients with MM in Nanjing School of Clinical Medicine from January 2004 to May 2012 were analyzed retrospectively. These patients were divided into 3 groups: glomerular damage group (n = 143), tubular damage group (n = 114) and normal group (n = 21). The clinical and laboratorial data were compared among them. The correlations of urinary retinol-binding protein (RBP) or urinary N-acetyl-β-D-amino-glucosaminidase (NAG) with blood urea nitrogen (BUN), Scr, blood cystatin-C (Cys-C), clearance of creatinine (Ccr), 24 h protein uria and 24 h urine light chains were further analyzed, and the correlation of renal tubulointerstitial lesion scores with low molecular weight urinary proteins in 61 patients were also analyzed. The area under curve (ROC curve) was used to evaluate and compare the discrimination of urinary RBP and urinary NAG. The results showed that glomerular damage group had higher urinary RBP than tubular damage group. However, glomerular damage group had lower urinary NAG than tubular damage group. The two groups had higher urinary RBP and urinary NAG than that in normal group. Urinary RBP related positively to the level of Scr, BUN, Cys-C, 24 h proteinurias and related negatively to the level of Ccr. Urinary NAG related positively to the level of 24 h proteinurias, Ccr and related negatively to the level of Cys-C. Renal tubulointerstitial lesions were significantly correlated with urinary RBP, but weakly correlated with urinary NAG. It is concluded that urinary RBP significantly correlates with renal tubular damage. Compared with urinary NAG, urinary RBP can better assess the extent of renal damage, and has higher specificity.
authors.affiliation: Department of Hematology, Nanjing General Hospital of Nanjing Military Area, Nanjing, Jiangsu Province, China.
authors.forename: Shi-Jing
authors.initials: SJ
authors.lastname: Liu
authors.forename: Yong-Ping
authors.initials: YP
authors.lastname: Zhai
authors.forename: Ya-Ping
authors.initials: YP
authors.lastname: Yu
authors.forename: Hai-Ning
authors.initials: HN
authors.lastname: Liu
authors.forename: Feng
authors.initials: F
authors.lastname: Li
authors.forename: Ping
authors.initials: P
authors.lastname: Song
authors.forename: Xiao-Gang
authors.initials: XG
authors.lastname: Zhou
authors.forename: Zhi-Ming
authors.initials: ZM
authors.lastname: An
authors.forename: Jing-Jing
authors.initials: JJ
authors.lastname: Shao
authors.forename: Xiao-Yan
authors.initials: XY
authors.lastname: Yang
mesh_terms: D000118:Acetylglucosaminidase / Q000652:urine*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D007668:Kidney / Q000473:pathology; D007674:Kidney Diseases / Q000175:diagnosis* / Q000473:pathology; D007684:Kidney Tubules / Q000473:pathology; D008297:Male; D008875:Middle Aged; D008970:Molecular Weight; D009101:Multiple Myeloma / Q000473:pathology* / Q000652:urine; D011507:Proteinuria; D012177:Retinol-Binding Proteins / Q000652:urine*; D012189:Retrospective Studies
chemical_list: D012177:Retinol-Binding Proteins; D000118:Acetylglucosaminidase